Back to Search Start Over

Clinically relevant benzoxaboroles inhibit mRNA processing in Trypanosoma brucei

Authors :
Albina Waithaka
Christine Clayton
Source :
BMC Research Notes, Vol 15, Iss 1, Pp 1-6 (2022)
Publication Year :
2022
Publisher :
BMC, 2022.

Abstract

Abstract Objective The cleavage and polyadenylation endonuclease CPSF73 is thought to be the target of the anti-trypanosomal benzoxaboroles AN7973, acoziborole and AN11736. We previously showed that AN7973 inhibits mRNA processing. We here investigated whether the drug candidates acoziborole (for human sleeping sickness) and AN11736 (for nagana in cattle) have the same effect. We also affinity purified tagged CPSF73 from parasites without, or after, AN7973 treatment, and analysed differentially co-purified proteins by mass spectrometry. Results AN11736 and acoziborole both inhibited mRNA processing, as demonstrated by decreased levels of spliced mRNAs and accumulation of di- and tri-cistronic mRNAs from the alpha-beta tubulin locus. Treating the cells with AN7973 for 30 min. did not significantly affect the proteins that copurified with CPSF73.

Details

Language :
English
ISSN :
17560500
Volume :
15
Issue :
1
Database :
Directory of Open Access Journals
Journal :
BMC Research Notes
Publication Type :
Academic Journal
Accession number :
edsdoj.1264f1b93dd4eda8db540df3ad2e24e
Document Type :
article
Full Text :
https://doi.org/10.1186/s13104-022-06258-y